BioCardia (BCDA) EBIT Margin Growth (1y) (2012 - 2024)
Powered by 
Analysis
BioCardia (BCDA) EBIT Margin Growth (1y) (2012 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 377.00 |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -4.69 Mn |
| Mar 31, 2024 | 134,801.00 |
| Dec 31, 2023 | -1.32 Mn |
| Sep 30, 2023 | 71,567.00 |
| Jun 30, 2023 | -777,164.00 |
| Mar 31, 2023 | 6,062.00 |
| Dec 31, 2022 | 153,384.00 |
| Sep 30, 2022 | -111,355.00 |
| Jun 30, 2022 | 480,026.00 |
| Mar 31, 2022 | 91,587.00 |
| Dec 31, 2021 | 322,334.00 |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 818,052.00 |
| Mar 31, 2021 | 566,808.00 |
| Dec 31, 2020 | -596,016.00 |
| Sep 30, 2020 | -965,424.00 |
| Jun 30, 2020 | -886,262.00 |
| Mar 31, 2020 | -1.04 Mn |
| Dec 31, 2019 | 190,921.00 |
| Sep 30, 2019 | 258,660.00 |